Triple

T17377773
Position Surface form Disambiguated ID Type / Status
Subject Bicycle Therapeutics E422484 entity
Predicate hasClinicalCandidate P127253 FINISHED
Object BT8009
BT8009 is an experimental cancer therapy developed by Bicycle Therapeutics, based on their bicyclic peptide platform to selectively target and kill tumor cells.
E1266362 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: BT8009 | Statement: [Bicycle Therapeutics, hasClinicalCandidate, BT8009]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: BT8009
Context triple: [Bicycle Therapeutics, hasClinicalCandidate, BT8009]
  • A. BT8
    BT8 is a postcode district in the BT (Belfast) postcode area of Northern Ireland, covering parts of south and southeast Belfast and surrounding suburbs.
  • B. BT20
    BT20 is a postcode district in the BT (Belfast) postcode area of Northern Ireland, covering parts of Bangor and the surrounding region.
  • C. BT28
    BT28 is a postal district in the BT postcode area of Northern Ireland, covering parts of Lisburn and its surrounding region.
  • D. BT06
    BT06 is the station code assigned to Guanzhuang Station on the Beijing Subway network.
  • E. B8
    B8 is the eighth-generation Volkswagen Passat, a mid-size family car known for its refined design, advanced technology, and efficient powertrains.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: BT8009
Triple: [Bicycle Therapeutics, hasClinicalCandidate, BT8009]
Generated description
BT8009 is an experimental cancer therapy developed by Bicycle Therapeutics, based on their bicyclic peptide platform to selectively target and kill tumor cells.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: BT8009
Target entity description: BT8009 is an experimental cancer therapy developed by Bicycle Therapeutics, based on their bicyclic peptide platform to selectively target and kill tumor cells.
  • A. BT8
    BT8 is a postcode district in the BT (Belfast) postcode area of Northern Ireland, covering parts of south and southeast Belfast and surrounding suburbs.
  • B. BT20
    BT20 is a postcode district in the BT (Belfast) postcode area of Northern Ireland, covering parts of Bangor and the surrounding region.
  • C. BT28
    BT28 is a postal district in the BT postcode area of Northern Ireland, covering parts of Lisburn and its surrounding region.
  • D. BT06
    BT06 is the station code assigned to Guanzhuang Station on the Beijing Subway network.
  • E. B8
    B8 is the eighth-generation Volkswagen Passat, a mid-size family car known for its refined design, advanced technology, and efficient powertrains.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: hasClinicalCandidate
Context triple: [Bicycle Therapeutics, hasClinicalCandidate, BT8009]
  • A. hasClinicalService
    Indicates that an entity provides, offers, or is associated with a specific clinical service.
  • B. hasKeyClinicalTrial
    Indicates that an entity is associated with a primary or pivotal clinical trial that is especially important for its evaluation or approval.
  • C. hasClinicalSignificance
    Indicates that something (such as a finding, variant, or condition) has a meaningful impact or relevance in a clinical or medical context.
  • D. hasPreclinicalFeature
    Indicates that an entity exhibits a characteristic, sign, or attribute that is present before the full clinical manifestation of a condition or disease.
  • E. hasDiagnosticCriterion
    Indicates that a specific diagnostic criterion is used to define, identify, or determine the presence of a particular condition, disorder, or classification.
  • F. None of above. chosen

Provenance (7 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d889d6535c81908be333c01deaec4e completed April 10, 2026, 5:25 a.m.
NER Named-entity recognition batch_69e43a6ea56c8190b56d966ccf2c91f7 completed April 19, 2026, 2:14 a.m.
NED1 Entity disambiguation (via context triple) batch_6a019ff344a881908f0870ac7ce8e120 completed May 11, 2026, 9:22 a.m.
NEDg Description generation batch_6a01a089ac0081908a746c0c25cc12be completed May 11, 2026, 9:25 a.m.
NED2 Entity disambiguation (via description) batch_6a01a1c415dc8190ba8f7e2a8053917f completed May 11, 2026, 9:30 a.m.
PD Predicate disambiguation batch_69e3b02ac8688190a7182f1b2151d721 completed April 18, 2026, 4:24 p.m.
PDg Predicate description generation batch_69e3b2a33e8481908fa6ef45290d08aa completed April 18, 2026, 4:34 p.m.
Created at: April 10, 2026, 5:45 a.m.